Patent · US Expired

Prodrugs of an ERK protein kinase inhibitor

US7358258B2 · kind B2 · utility

23Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 13, 2005
Grant dateApr 15, 2008
Priority date
Expiry dateMay 13, 2025

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.